Table of Contents Author Guidelines Submit a Manuscript
TheScientificWorldJOURNAL
Volume 10, Pages 1768-1782
http://dx.doi.org/10.1100/tsw.2010.164
Review Article

Role of Adenosine A2A Receptors in Modulating Synaptic Functions and Brain Levels of BDNF: a Possible Key Mechanism in the Pathophysiology of Huntington's Disease

Department of Therapeutic Research and Medicine Evaluation, Istituto Superiore di Sanità, Rome, Italy

Received 28 May 2010; Revised 22 July 2010; Accepted 22 July 2010

Academic Editor: Sergi Ferre

Copyright © 2010 Maria Teresa Tebano et al.

Citations to this Article [22 citations]

The following is the list of published articles that have cited the current article.

  • Youssef Sari, “Potential drugs and methods for preventing or delaying the progression of huntington's disease,” Recent Patents on CNS Drug Discovery, vol. 6, no. 2, pp. 80–90, 2011. View at Publisher · View at Google Scholar
  • David J. Eve, Cesar V. Borlongan, and Paul R. Sanberg, “A Showcase of Bench-to-Bedside Regenerative Medicine at the 2010 ASNTR,” The Scientific World JOURNAL, vol. 11, pp. 1842–1864, 2011. View at Publisher · View at Google Scholar
  • Nai-Kuei Huang, Jung-Hsin Lin, Jiun-Tsai Lin, Chia-I Lin, Eric Minwei Liu, Chun-Jung Lin, Wan-Ping Chen, Yuh-Chiang Shen, Hui-Mei Chen, Jhih-Bin Chen, Hsing-Lin Lai, Chieh-Wen Yang, Ming-Chang Chiang, Yu-Shuo Wu, Chen Chang, Jiang-Fan Chen, Jim-Min Fang, Yun-Lian Lin, and Yijuang Chern, “A new drug design targeting the adenosinergic system for huntington's disease,” PLoS ONE, vol. 6, no. 6, 2011. View at Publisher · View at Google Scholar
  • V. Ghiglieri, V. Bagetta, P. Calabresi, and B. Picconi, “Functional interactions within striatal microcircuit in animal models of Huntington's disease,” Neuroscience, vol. 211, pp. 165–184, 2012. View at Publisher · View at Google Scholar
  • Ainhi Ha, and Joseph Jankovic, “Huntington Disease and Other Genetic Choreas,” Hyperkinetic Movement Disorders, pp. 147–174, 2012. View at Publisher · View at Google Scholar
  • P. Hemachandra Reddy, and Ulziibat P. Shirendeb, “Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease,” Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, vol. 1822, no. 2, pp. 101–110, 2012. View at Publisher · View at Google Scholar
  • Thomas Endres, and Volkmar Lessmann, “Age-dependent deficits in fear learning in heterozygous BDNF knock-out mice,” Learning & Memory, vol. 19, no. 12, pp. 561–570, 2012. View at Publisher · View at Google Scholar
  • Veronica Ghiglieri, Vincenza Bagetta, Valentina Pendolino, Barbara Picconi, and Paolo Calabresi, “Corticostriatal Plastic Changes in Experimental L-DOPA-Induced Dyskinesia,” Parkinson's Disease, vol. 2012, pp. 1–10, 2012. View at Publisher · View at Google Scholar
  • Clémence Simonin, Cécile Duru, Julia Salleron, Pascale Hincker, Perrine Charles, Arnaud Delval, Katia Youssov, Sylvie Burnouf, Jean-Philippe Azulay, Christophe Verny, Clarisse Scherer, Christine Tranchant, Cyril Goizet, Sabrina Debruxelles, Luc Defebvre, Bernard Sablonnière, Monique Romon-Rousseaux, Luc Buée, Alain Destée, Olivier Godefroy, Alexandra Dürr, Bernhard Landwehrmeyer, Anne-Catherine Bachoud-Levi, Florence Richard, David Blum, and Pierre Krystkowiak, “Association between caffeine intake and age at onset in Huntington's disease,” Neurobiology of Disease, 2013. View at Publisher · View at Google Scholar
  • Izaskun Villar-Menéndez, Marta Blanch, Shiraz Tyebji, Thais Pereira-Veiga, José Luis Albasanz, Mairena Martín, Isidre Ferrer, Esther Pérez-Navarro, and Marta Barrachina, “Increased 5-Methylcytosine and Decreased 5-Hydroxymethylcytosine Levels are Associated with Reduced Striatal A2AR Levels in Huntington’s Disease,” NeuroMolecular Medicine, vol. 15, no. 2, pp. 295–309, 2013. View at Publisher · View at Google Scholar
  • David Blum, Luísa V. Lopes, Ursula Sandau, Cyril Laurent, Vânia Batalha, Antoine Leboucher, Malika Hamdane, Florence Pasquier, Detlev Boison, and Luc Buéepp. 385–407, 2013. View at Publisher · View at Google Scholar
  • Hakim Houchi, Wolfgang Persyn, Rémi Legastelois, and Mickaël Naassila, “The adenosine A2A receptor agonist CGS 21680 decreases ethanol self-administration in both non-dependent and dependent animals,” Addiction Biology, 2013. View at Publisher · View at Google Scholar
  • Antonella Ferrante, Alberto Martire, Rita Pepponi, Katia Varani, Fabrizio Vincenzi, Luca Ferraro, Sarah Beggiato, Maria Teresa Tebano, and Patrizia Popoli, “Expression, pharmacology and functional activity of adenosine A1 receptors in genetic models of Huntington's disease,” Neurobiology of Disease, 2014. View at Publisher · View at Google Scholar
  • Rafael Perígolo-Vicente, Karen Ritt, Cassiano Felippe Gonçalves-de-Albuquerque, Hugo Caire Castro-Faria-Neto, Roberto Paes-de-Carvalho, and Elizabeth Giestal-de-Araujo, “IL-6, A1 and A2aR: a crosstalk that modulates BDNF and induces neuroprotection,” Biochemical and Biophysical Research Communications, 2014. View at Publisher · View at Google Scholar
  • Anne Petzold, Laura Psotta, Tanja Brigadski, Thomas Endres, and Volkmar Lessmann, “Chronic BDNF deficiency leads to an age-dependent impairment in spatial learning,” Neurobiology of Learning and Memory, 2015. View at Publisher · View at Google Scholar
  • F.F. Ribeiro, S. Xapelli, C. Miranda-Lourenço, S.R. Tanqueiro, J. Fonseca-Gomes, M.J. Diógenes, J.A. Ribeiro, and A.M. Sebastião, “Purine nucleosides in neuroregeneration and neuroprotection,” Neuropharmacology, 2015. View at Publisher · View at Google Scholar
  • Silvia Bassi, Takshashila Tripathi, Alan Monziani, Francesca Di Leva, and Marta Biagioli, “Epigenetics of Huntington’s Disease,” Neuroepigenomics in Aging and Disease, vol. 978, pp. 277–299, 2017. View at Publisher · View at Google Scholar
  • Danielle A. Simmons, “Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease,” Journal of Huntington's Disease, vol. 6, no. 4, pp. 303–325, 2017. View at Publisher · View at Google Scholar
  • Antonella Ferrante, Antonella Pezzola, Andrea Matteucci, Antonella di Biase, Lucilla Attorri, Monica Armida, Alberto Martire, Yijuang Chern, and Patrizia Popoli, “The adenosine A 2A receptor agonist T1–11 ameliorates neurovisceral symptoms and extends the lifespan of a mouse model of Niemann-Pick type C disease,” Neurobiology of Disease, 2017. View at Publisher · View at Google Scholar
  • Stephen M. Massa, Danielle A. Simmons, and Frank M. Longo, “Neurotrophin receptor signaling as a therapeutic target for Huntington’s disease,” CNS and Neurological Disorders - Drug Targets, vol. 16, no. 3, pp. 291–302, 2017. View at Publisher · View at Google Scholar
  • Maria Rosaria Domenici, Valentina Chiodi, Mirko Averna, Monica Armida, Antonella Pèzzola, Rita Pepponi, Antonella Ferrante, Michael Bader, Kjell Fuxe, and Patrizia Popoli, “Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington’s disease,” Purinergic Signalling, 2018. View at Publisher · View at Google Scholar
  • Ágatha Oliveira-Giacomelli, Yahaira Naaldijk, Laura Sardá-Arroyo, Maria C. B. Gonçalves, Juliana Corrêa-Velloso, Micheli M. Pillat, Héllio D. N. de Souza, and Henning Ulrich, “Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy,” Frontiers in Pharmacology, vol. 9, 2018. View at Publisher · View at Google Scholar